Global Blood Cancer Market Forecast to 2028

血液がんの世界市場予測2019-2029

◆タイトル:Global Blood Cancer Market Forecast to 2028
◆商品コード:VGN906171
◆調査・発行会社:visiongain
◆発行日:2019年4月
◆ページ数:92
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:産業未分類
◆販売価格オプション(消費税別)
Sigle UserGBP3,499 ⇒換算¥475,864見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算¥530,264見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算¥679,864見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"血液がんの世界市場予測2019-2029"について調査・分析し、レポートサマリー、市場動向、世界市場規模・市場予測、種類別分析、研究開発パイプライン分析、主要企業分析、結論、提言などの情報をお届けいたします。

The global blood cancer market reached $24bn in 2018 and is estimated to grow at a CAGR of 6.4% in the first half of the forecast period. Chemotherapy held 44% of the market in 2018.How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand-new report you will receive 61 charts – all unavailable elsewhere.
This report provides clear detailed insight into the global blood cancer market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Revenue and growth forecasts to 2028 for the blood cancer market
• Revenue and growth forecast to 2028 for the blood cancer market by type of therapy:
• Chemotherapy
• Targeted therapy
• Immunotherapy
• Revenue and growth forecast to 2028 for the blood cancer market by regional and national market:
• The US
• Japan
• Germany
• France
• The UK
• Spain
• Italy
• Brazil
• Russia
• India
• China

For each national market, the revenue forecast is also broken down by submarket.
• For each national market, this report provides incident cases projection from 2018 to 2028 for:
• Leukaemia
• Non-Hodgkin Lymphoma
• Hodgkin Lymphoma
• Multiple Myeloma
• Discussion and profiles of the leading players in the blood cancer market:
• Amgen
• AstraZeneca
• Bayer
• Bristol-Myers Squibb (BMS)
• Celgene
• Johnson & Johnson
• Novartis
• Pfizer
• Roche
• Discussion on drugs that are currently in the R&D pipeline for Leukaemia, Lymphoma and Multiple Myeloma.
• Analysis of what stimulates and restrains the global blood cancer market: Porter’s Five Forces Analysis, Trends, Drivers and Challenges
• Key Questions Answered by this Report:
• How is the Blood Cancer market evolving?
• What are the drivers and restraints for the growth of the Blood Cancer market?
• How will each Blood Cancer submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2028?
• What will be the main driver for the overall market to 2028?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national Blood Cancer markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2028 and which geographical region will lead the market in 2028?
• Who are the leading players and what are their prospects over the forecast period?
Visiongain’s study is intended for anyone requiring commercial analyses for the global blood cancer market. You find data, trends and predictions.
Buy our report today Global Blood Cancer Market Forecast to 2028: Immunotherapy, Chemotherapy, Targeted Therapy.

【レポートの目次】

1. Report Overview
1.1 Global Blood Cancer Market Overview
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Why You Should Read This Report
1.5 How This Report Delivers
1.6 Key Questions Answered by This Analytical Report
1.7 Who is This Report For?
1.8 Methodology
1.8.1 Primary Research
1.8.2 Secondary Research
1.8.3 Market Evaluation & Forecasting Methodology
1.9 Frequently Asked Questions (FAQ)
1.10 Associated Visiongain Reports
1.11 About Visiongain

2. The Global Blood Cancer Market by Therapy Area: Incident Cases by Country 2018-2018
2.1 Overview of Blood Cancer
2.2 Signs and Symptoms
2.3 Causes of Blood Cancer
2.4 Blood Cancer Treatment & Therapy Options
2.5 Leukaemia
2.5.1 Acute Lymphocytic Leukaemia (ALL) in Adults
2.5.2 Acute Myeloid Leukaemia (AML)
2.5.3 Chronic Lymphocytic Leukaemia (CLL)
2.5.4 Chronic Myeloid Leukaemia (CML)
2.5.5 Chronic Myelomonocytic Leukaemia
2.5.6 Leukaemia in Children
2.5.7 Survival
2.6 Lymphoma
2.6.1 Non-Hodgkin lymphomas
2.6.2 Hodgkin disease
2.6.3 Survival
2.7 Myeloma
2.7.1 Survival

3. The Global Blood Cancer Market by Type of Therapy: Market Forecast to 2028
3.1 An Introduction to Various Types of Therapies
3.2 Chemotherapy
3.2.1 Global Chemotherapy Market Forecast to 2028
3.3.1 Global Targeted Therapy Market Forecast to 2028
3.4 Immunotherapy
3.4.1 Global Immunotherapy Market Forecast to 2028

4. Global Blood Cancer Market by Region: Market Forecast to 2028
4.1 An Introduction to the Market Geography
4.2 United States Blood Cancer Market Forecast to 2028
4.2.1 United States Blood Cancer Market by Disease Type
4.2.2 United States Blood Cancer Market by Type of Therapy: Forecast to 2028
4.3 EU5 Blood Cancer Market Forecast to 2028
4.3.1 EU5 Blood Cancer Market by Disease Type
4.3.2 EU5 Blood Cancer Market Forecast by Type of Therapy: Forecast to 2028
4.3.3 EU5 Blood Cancer Market by Country Share, 2018 and 2028
4.4 BRIC Blood Cancer Market Forecast to 2028
4.4.1 BRIC Blood Cancer Market by Disease Type
4.4.2 BRIC Blood Cancer Market by Type of Therapy: Forecast to 2028
4.4.3 BRIC Countries Blood Cancer Market
4.4.3.1 Brazil
4.4.3.2 India
4.4.3.3 Russia
4.4.3.4 China
4.4 Japan Blood Cancer Market Forecast to 2028
4.4.1 Japan Blood Cancer Market: by Disease Type
4.4.2 Japan Blood Cancer Market by Type of Therapy: Forecast to 2028

5. Leading Companies in the Blood Cancer Market
5.1 Introduction
5.1.1 Amgen Inc.
5.1.1.1 Business Overview
5.1.1.2 Recent Financials
5.1.1.3 Product Offerings
5.1.1.4 Recent developments
5.1.2 AstraZeneca PLC
5.1.2.1 Business Overview
5.1.2.2 Recent Financials
5.1.2.3 Product Offerings
5.1.2.4 Recent developments
5.1.3 Bayer AG
5.1.3.1 Business Overview
5.1.3.2 Recent Financials
5.1.3.3 Product Offerings
5.1.3.4 Recent developments
5.1.4 Bristol-Myers Squibb Company
5.1.4.1 Business Overview
5.1.4.2 Recent Financials
5.1.4.3 Product Offerings
5.1.4.4 Recent developments
5.1.5 Celgene Corporation
5.1.5.1 Business Overview
5.1.5.2 Recent Financials
5.1.5.3 Product Offerings
5.1.5.4 Recent developments
5.1.6 Roche
5.1.6.1 Business Overview
5.1.6.2 Recent Financials
5.1.6.3 Product Offerings
5.1.6.4 Recent developments
5.1.7 Johnson & Johnson
5.1.7.1 Business Overview
5.1.7.2 Recent Financials
5.1.8 Novartis
5.1.8.1 Business Overview
5.1.8.2 Recent Financials
5.1.8.3 Product Offerings
5.1.8.4 Recent developments
5.1.9 Pfizer Inc.
5.1.9.1 Business Overview
5.1.9.2 Recent Financials
5.1.9.3 Product Offerings
5.1.9.4 Recent Developments

6. Blood Cancer: R&D Pipeline
6.1 Blood Cancer: R&D Pipeline
6.1.1 Drugs for Leukemia
6.1.2 Drugs for Lymphoma
6.1.3 Multiple Myeloma
6.1.4 Other Major Drugs Under Different Stages of Development

7. Qualitative Analysis
7.1. Porter’s Five Forces Analysis
7.1.1. Bargaining power of buyers (MEDIUM)
7.1.2 Bargaining power of suppliers (LOW)
7.1.3 Industry rivalry (HIGH)
7.1.4 Threat of new entrants
7.1.5 Threat of substitutes (HIGH)
7.2 Market Dynamics of Blood Cancer Market
7.2.1 Trends
7.2.2 Drivers
7.2.3 Challenges

8. Conclusions & Recommendations
8.1 Key Takeaway
8.2 Conclusion

Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain Report Evaluation Form

List of Tables
Table 2.1 Incident Cases of Leukaemia by Country: 2018-2028
Table 2.2 Incident cases of Non-Hodgkin Lymphoma (NHL) by Country: 2018-2028
Table 2.3 Incident Cases of Hodgkin Lymphoma (HL) by Country: 2018-2028
Table 2.4 Incident cases of Multiple Myeloma by Country: 2018-2028
Table 3.1 Global Blood Cancer Market Forecast: Revenue ($bn), AGR (%), CAGR (%), 2018-2028
Table 3.2 Global Chemotherapy Market Forecast 2018-2028: Revenue ($bn), AGR (%), CARG (%), 2018-2028
Table 3.3 Global Targeted Therapy Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 3.4 Global Immunotherapy Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 4.1 United States Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 4.2 Incident Cases of Different Types of Cancers in the US: 2018-2028
Table 4.3: United States Blood Cancer Market Forecast by Type of Therapy: Revenue ($bn), AGR (%), CAGR (%)
Table 4.4 EU5 Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 4.5 Incident Cases of Different Types of Cancers in the EU5
Table 4.6 EU5 Blood Cancer Market Forecast by Type of Therapy: Revenue ($bn), AGR (%), CAGR (%)
Table 4.7 BRIC Blood Cancer Market Forecast 2018-2028 by Country: Revenue ($bn), AGR (%), CAGR (%)
Table 4.8 Incident Cases of Different Types of Cancers in BRIC Countries: 2018-2028
Table 4.9 BRIC Countries Blood Cancer Market Forecast by Type of Therapy: Revenue ($bn), 2018-2028
Table 4.10 Japan Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%), CAGR (%)
Table 4.11 Incident Cases of Different Types of Cancers in Japan: 2018-2028
Table 4.12 Japan Blood Cancer Market Forecast by Type of Therapy: Revenue ($bn), 2018-2028
Table 5.1 Amgen Inc.: Key Facts
Table 5.2 Amgen Inc.: Financial Information 2016-2017
Table 5.3 AstraZeneca PLC: Key Facts
Table 5.4 AstraZeneca PLC: Financial Information 2016-2017
Table 5.5 Bayer AG: Key Facts
Table 5.6 Bayer AG: Recent Financials 2016-2017
Table 5.7 Bristol-Myers Squibb Company – Key Facts
Table 5.8 Bristol-Myers Squibb: Recent Financials 2016-2017
Table 5.9 Celgene Corporation: Key Facts
Table 5.10 Celgene: Recent Financials 2016-2017
Table 5.11 Roche: Key Facts
Table 5.12 Roche: Recent Financials 2016-2017
Table 5.13 Johnson & Johnson: Key Facts
Table 5.14 Johnson & Johnson: Recent Financials 2016-2017
Table 5.15 Novartis AG: Key Facts
Table 5.16 Novartis: Recent Financials 2016-2017
Table 5.17 Pfizer Inc.: Key Facts
Table 5.18 Pfizer Inc.: Recent Financials 2016-2017
Table 6.1 Major Drugs Udder Development

List of Figures
Figure 2.1 Types of Blood Cancer
Figure 2.2 Different Types of Leukaemia
Figure 2.3 Trend of Leukaemia Cases by Country: 2018-2028
Figure 2.4 Trend of Non-Hodgkin Lymphoma (NHL) by Country: 2018-2028
Graph 2.5 Trend of Hodgkin Lymphoma (NHL) by Country: 2018-2028
Figure 2.6 Trend of Multiple Myeloma by Country: 2018-2028
Figure 3.1 Market Size of Cancer Therapy by Type ($bn): 2018-2028
Figure 3.2 Market share (%) of Cancer Therapy by Type: 2018 and 2028
Figure 3.3: Global Chemotherapy Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 3.4 Global Targeted Therapy Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 3.5 Global Immunotherapy Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.1 Blood Cancer Market by Region: % Share, 2018
Figure 4.2 Blood Cancer Market by Region: % Share, 2028
Figure 4.3: United States Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.4: Distribution of Different Types of Blood Cancer in the US: 2018-2028
Figure 4.5: EU5 Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.6 EU5 Blood Cancer Market by Country: % Share, 2018 and 2028
Figure 4.7: BRIC Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.8: Japan Blood Cancer Market Forecast 2018-2028: Revenue ($bn), AGR (%)
Figure 4.9: Distribution of Different Types of Blood Cancer in Japan: 2018-2028
Figure 8.1: Global Blood Cancer Market by Region: Revenue ($bn), 2018
Figure 8.2: Global Blood Cancer Market by Region: Revenue ($bn), 2018



★調査レポート[血液がんの世界市場予測2019-2029] ( Global Blood Cancer Market Forecast to 2028 / VGN906171) 販売に関する免責事項
[血液がんの世界市場予測2019-2029] ( Global Blood Cancer Market Forecast to 2028 / VGN906171) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆